相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Targeted Dual Small Interfering Ribonucleic Acid Delivery via Non-Viral Polymeric Vectors for Pulmonary Fibrosis Therapy
Qijian Ji et al.
ADVANCED MATERIALS (2021)
Targeting Runt-Related Transcription Factor 1 Prevents Pulmonary Fibrosis and Reduces Expression of Severe Acute Respiratory Syndrome Coronavirus 2 Host Mediators
Michael O'Hare et al.
AMERICAN JOURNAL OF PATHOLOGY (2021)
Human antigen R promotes lung fibroblast differentiation to myofibroblasts and increases extracellular matrix production
Fatmah Al-Habeeb et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2021)
Post-translational Control of RNA-Binding Proteins and Disease-Related Dysregulation
Alejandro Velazquez-Cruz et al.
FRONTIERS IN MOLECULAR BIOSCIENCES (2021)
RUNX1 regulates SMAD1 by transcriptionally activating the expression of USP9X, regulating the activation of hepatic stellate cells and liver fibrosis
Jie Huang et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2021)
TNF-α signaling regulates RUNX1 function in endothelial cells
Hannah A. B. Whitmore et al.
FASEB JOURNAL (2021)
Targeting exosome-associated human antigen R attenuates fibrosis and inflammation in diabetic heart
Prem Kumar Govindappa et al.
FASEB JOURNAL (2020)
RUNX1: an emerging therapeutic target for cardiovascular disease
Alexandra Riddell et al.
CARDIOVASCULAR RESEARCH (2020)
RUNX1 regulates TGF-β induced migration and EMT in colorectal cancer
Chenghao Lu et al.
PATHOLOGY RESEARCH AND PRACTICE (2020)
LncRNA Hoxaas3 promotes lung fibroblast activation and fibrosis by targeting miR-450b-5p to regulate Runx1
Shuang Lin et al.
CELL DEATH & DISEASE (2020)
The HuR CMLD-2 inhibitor exhibits antitumor effects via MAD2 downregulation in thyroid cancer cells
Lorenzo Allegri et al.
SCIENTIFIC REPORTS (2019)
Human antigen R as a therapeutic target in pathological cardiac hypertrophy
Lisa C. Green et al.
JCI INSIGHT (2019)
Idiopathic Pulmonary Fibrosis
David J. Lederer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Runt-Related Transcription Factor 1 (RUNX1) Promotes TGF-β-Induced Renal Tubular Epithelial-to-Mesenchymal Transition (EMT) and Renal Fibrosis through the PI3K Subunit p110δ
Tong Zhou et al.
EBIOMEDICINE (2018)
Runx1 Deficiency Protects Against Adverse Cardiac Remodeling After Myocardial Infarction
Charlotte S. McCarroll et al.
CIRCULATION (2018)
M2 macrophages promote myofibroblast differentiation of LR-MSCs and are associated with pulmonary fibrogenesis
Jiwei Hou et al.
CELL COMMUNICATION AND SIGNALING (2018)
Impact of novel antifibrotic therapy on patient outcomes in idiopathic pulmonary fibrosis: patient selection and perspectives
Bridget A. Graney et al.
PATIENT-RELATED OUTCOME MEASURES (2018)
Idiopathic Pulmonary Fibrosis: Current Status, Recent Progress, and Emerging Targets
Yi-Min Liu et al.
JOURNAL OF MEDICINAL CHEMISTRY (2017)
Arid5a-deficient mice are highly resistant to bleomycin-induced lung injury
Praveen Kumar Dubey et al.
INTERNATIONAL IMMUNOLOGY (2017)
Endothelial to haematopoietic transition contributes to pulmonary arterial hypertension
Olin D. Liang et al.
CARDIOVASCULAR RESEARCH (2017)
Transforming growth factor beta (TGF-β) mediates cardiac fibrosis and induces diabetic cardiomyopathy
Yiyang Yue et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2017)
RUNX1 induces DNA replication independent of active DNA demethylation at SPI1 regulatory regions
Shubham Goyal et al.
BMC MOLECULAR BIOLOGY (2017)
AREsite2: an enhanced database for the comprehensive investigation of AU/GU/U-rich elements
Joerg Fallmann et al.
NUCLEIC ACIDS RESEARCH (2016)
Impact of HuR inhibition by the small molecule MS-444 on colorectal cancer cell tumorigenesis
Fernando F. Blanco et al.
ONCOTARGET (2016)
Idiopathic pulmonary fibrosis: combating on a new turf
Ganesh Raghu
LANCET RESPIRATORY MEDICINE (2016)
A Phase 3 Trial of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis
Talmadge E. King et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Efficacy and Safety of Nintedanib in Idiopathic Pulmonary Fibrosis
Luca Richeldi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
RUNX1 is essential for mesenchymal stem cell proliferation and myofibroblast differentiation
Woosook Kim et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Antiflammin-1 attenuates bleomycin-induced pulmonary fibrosis in mice
Wei Liu et al.
RESPIRATORY RESEARCH (2013)
PROFILEing idiopathic pulmonary fibrosis: rethinking biomarker discovery
Toby M. Maher
EUROPEAN RESPIRATORY REVIEW (2013)
Expression of RUNX1 isoforms and its target gene BLK in childhood acute lymphoblastic leukemia
Oreth Montero-Ruiz et al.
LEUKEMIA RESEARCH (2012)
An Official ATS/ERSARS/ALAT Statement: Idiopathic Pulmonary Fibrosis: Evidence-based Guidelines for Diagnosis and Management
Ganesh Raghu et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2011)
Integrating mechanisms of pulmonary fibrosis
Thomas A. Wynn
JOURNAL OF EXPERIMENTAL MEDICINE (2011)
Determinants of initiation and progression of idiopathic pulmonary fibrosis
Robert Matthew Kottmann et al.
RESPIROLOGY (2009)
TGF-β, Smad3 and the process of progressive fibrosis
J. Gauldie et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2007)
The RUNX genes: Gain or loss of function in cancer
K Blyth et al.
NATURE REVIEWS CANCER (2005)
Expression of apoptotic and antiapoptotic markers in epithelial cells in idiopathic pulmonary fibrosis
M Plataki et al.
CHEST (2005)
Runx1 is essential for hematopoietic commitment at the hemangioblast stage of development in vitro
G Lacaud et al.
BLOOD (2002)
Idiopathic pulmonary fibrosis: an epithelial/fibroblastic cross-talk disorder
M Selman et al.
RESPIRATORY RESEARCH (2001)
Medical progress: Idiopathic pulmonary fibrosis.
TJ Gross et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
分享论文
